- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02523118
OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages (OMEGA)
A Prospective, Multicenter Study to Compare and Validate Endoscopic, Histologic, Molecular, and Patient-Reported Outcomes in Pediatric and Adult Patients With Eosinophilic Esophagitis (EoE), Gastritis (EG), Gastroenteritis (EGE) and Colitis (EC)
Study Overview
Status
Detailed Description
This is a longitudinal observational study in which individuals (males and females 3 years of age and greater) with EoE, EG, EGE and EC will be followed over the course of time to see if standard questionnaires can give us an idea of how well the person is doing.
Participants undergoing standard of care (normal, routine care) endoscopies and/or colonoscopies will have biopsies (small pieces of tissue from the GI tract normally collected during these procedures) collected and used for the research study. Participants will also complete questionnaires related to their symptoms and quality of life. Participants will be followed over the course of time and asked to complete the questionnaires at various time points throughout the study.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Kara Kliewer, PhD
- Phone Number: 513-636-4821
- Email: kara.kliewer@cchmc.org
Study Locations
-
-
Arkansas
-
Rogers, Arkansas, United States, 72758
- Recruiting
- Arkansas Children's Research Institute
-
Contact:
- Lori Lednick-Hayes
- Phone Number: 501-364-3755
- Email: lednick-hayesll@archildrens.org
-
Contact:
- Evie Cannon
- Phone Number: 501-364-6883
- Email: cannonek@archildrens.org
-
Principal Investigator:
- Robert Pesek, MD
-
-
California
-
San Diego, California, United States, 92123
- Recruiting
- Rady Children's Hospital
-
Contact:
- Kira Chaiboonma
- Phone Number: 226884 858-966-1700
- Email: kchaiboonma@health.ucsd.edu
-
Principal Investigator:
- Seema Aceves, M.D., PhD
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- Recruiting
- University of Colorado Denver
-
Principal Investigator:
- Paul Menard-Katcher, MD
-
Contact:
- Jonathan Cahoon
- Phone Number: 303-724-8974
- Email: jonathan.cahoon@ucdenver.edu
-
Denver, Colorado, United States, 80218
- Recruiting
- Children's Hospital Colorado
-
Contact:
- Cassandra Burger
- Phone Number: 720-777-5739
- Email: cassandra.burger@childrenscolorado.org
-
Principal Investigator:
- Glenn Furuta, M.D.
-
-
Illinois
-
Chicago, Illinois, United States, 60208
- Recruiting
- Northwestern University
-
Contact:
- Tenesha Thomas
- Email: tenesha.thomas@northwestern.edu
-
Principal Investigator:
- Ikuo Hirano, M.D.
-
Chicago, Illinois, United States, 60611
- Recruiting
- Ann and Robert H. Lurie Children's Hospital of Chicago
-
Contact:
- Katie Keeley
- Phone Number: 312-227-4546
- Email: kkeeley@luriechildrens.org
-
Principal Investigator:
- Joshua Wechsler, M.D.
-
-
Indiana
-
Indianapolis, Indiana, United States, 46202
- Recruiting
- Riley Children's Hospital
-
Principal Investigator:
- Sandeep Gupta, MD
-
Contact:
- Gail Waltz
- Email: gwaltz@iu.edu
-
-
Maryland
-
Bethesda, Maryland, United States, 20892
- Recruiting
- National Institutes of Health (NIH)
-
Principal Investigator:
- Paneez Khoury, MD
-
Contact:
- Perla Adames-Castillo
- Email: perla.adamescastillo@nih.gov
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02111
- Completed
- Tufts University
-
-
Minnesota
-
Rochester, Minnesota, United States, 55902
- Completed
- Mayo Clinic
-
-
New York
-
New York, New York, United States, 10029
- Recruiting
- Icahn School of Medicine at Mount Sinai
-
Contact:
- Grant Eickel
- Phone Number: 212-241-4908
- Email: grant.eickel@mssm.edu
-
Principal Investigator:
- Mirna Chehade, MD
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- Recruiting
- University of North Carolina, Chapel Hill
-
Contact:
- Sean Lafata
- Phone Number: 919-966-1757
- Email: sean_lafata@med.unc.edu
-
Principal Investigator:
- Evan Dellon, M.D., MPH
-
-
Ohio
-
Cincinnati, Ohio, United States, 45229
- Recruiting
- Cincinnati Children's Hospital Medical Center
-
Principal Investigator:
- Marc Rothenberg, MD, PhD
-
Contact:
- Lauren Turner, MS
- Phone Number: 513-636-4200
- Email: Lauren.Turner@cchmc.org
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Recruiting
- University of Pennsylvania
-
Contact:
- Lilly Hennessey
- Phone Number: 215-349-8222
- Email: lilly.hennessey@pennmedicine.upenn.edu
-
Contact:
- Maureen DeMarshall
- Phone Number: 215-349-8546
- Email: demarshm@mail.med.upenn.edu
-
Principal Investigator:
- Gary Falk, M.D., MS
-
Philadelphia, Pennsylvania, United States, 19104
- Recruiting
- Children's Hospital of Philadelphia
-
Principal Investigator:
- Jonathan Spergel, MD, PhD
-
Contact:
- Michael Pratt
- Phone Number: 215-590-2549
- Email: PRATTM2@chop.edu
-
Contact:
- Leah Wilkey
- Phone Number: (215)-590-6198
- Email: wilkeyl@email.chop.edu
-
-
Tennessee
-
Nashville, Tennessee, United States, 37232
- Recruiting
- Vanderbilt University Medical Center
-
Contact:
- Regina Tyree
- Phone Number: 615-343-6845
- Email: regina.n.tyree@vumc.org
-
Principal Investigator:
- Girish Hiremath, MD, MPH
-
-
Texas
-
Houston, Texas, United States, 77030
- Recruiting
- Baylor College of Medicine & Texas Children's Hospital
-
Contact:
- Amanda Vega
- Phone Number: 832-824-0939
- Email: amandav@bcm.edu
-
Contact:
- Daisy Vita (Tran)
- Phone Number: (832)-824-3640
- Email: dxtran1@texaschildrens.org
-
Principal Investigator:
- Carla Davis, MD
-
-
Utah
-
Salt Lake City, Utah, United States, 84112
- Recruiting
- University of Utah
-
Principal Investigator:
- Kathryn Peterson, MD
-
Contact:
- Brinnlie Harward
- Phone Number: 801-585-0894
- Email: Brinnlie.Harward@hsc.utah.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Males or females 3 years of age and older
- Mucosal eosinophilia: EoE ≥ 15 eosinophils/HPF in the distal or proximal esophagus, EG ≥ 30 eosinophils/HPF in 5 HPF's in the body and/or antrum, EGE ≥ 53 eosinophils/HPF in the duodenum and/or ≥ 56 eosinophils/HPF in the jejunum and/or ileum, EC ≥ 84 eosinophils/HPF from the transverse or descending colon and/or ≥ 32 eosinophils/HPF from the rectosigmoid colon or a biopsy from any colonic location with ≥ 100 eosinophils/HPF
- Presence of symptoms is required for patients who are newly diagnosed but not required for patients who were previously diagnosed.
Exclusion Criteria:
- History of intestinal surgery other than G tube placement
- Enrolled in a blinded investigational study at the time of the first study visit
- Have esophageal stricture (<3mm)
- Have other identifiable causes for eosinophilia (except Inflammatory Bowel Disease): infections, Gastrointestinal (GI) cancer, other GI inflammatory disease (e.g., Ulcerative Colitis or Crohn's Disease)
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Other
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mucosal eosinophilia (eos/hpf)
Time Frame: Duration of funding, at least 10 years
|
Mucosal eosinophil levels are measured as eosinophils per high power field (eos/hpf).
The primary outcome measure is to determine the change in mucosal eosinophil level (eos/hpf) and to determine if the change in mucosal eosinophil level in eos/hpf correlates with the change in scores on clinical outcome measure metrics.
|
Duration of funding, at least 10 years
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Marc E Rothenberg, MD, PhD, Children's Hospital Medical Center, Cincinnati
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Immune System Diseases
- Hypersensitivity, Immediate
- Hematologic Diseases
- Stomach Diseases
- Colonic Diseases
- Intestinal Diseases
- Hypersensitivity
- Esophageal Diseases
- Leukocyte Disorders
- Gastritis
- Gastrointestinal Diseases
- Digestive System Diseases
- Gastroenteritis
- Eosinophilic Esophagitis
- Enteritis
- Eosinophilia
- Colitis
- Esophagitis
Other Study ID Numbers
- 2015-2311
- U54AI117870 (Other Grant/Funding Number: NIDDK)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Eosinophilic Gastritis
-
Children's Hospital Medical Center, CincinnatiAstraZenecaCompletedEosinophilic Gastritis or GastroenteritisUnited States
-
Allakos Inc.CompletedEosinophilic Gastritis | Eosinophilic DuodenitisUnited States
-
Children's Hospital Medical Center, CincinnatiNational Institute of Allergy and Infectious Diseases (NIAID); National Institute... and other collaboratorsCompletedEosinophilic Gastritis | Eosinophilic Gastroenteritis | Eosinophilic Esophagitis | Eosinophilic ColitisUnited States
-
Arkansas Children's Hospital Research InstituteWithdrawnEosinophilic Gastritis | Eosinophilic Esophagitis | Eosinophilic Colitis | Eosinophilic EnteritisUnited States
-
IRCCS Policlinico S. MatteoItalian Society of Pediatric Allergy & Immunology - Pediatric CentersRecruitingEosinophilic Esophagitis | Eosinophilic Colitis | Eosinophilic Gastritis or Gastroenteritis | Eosinophilic Gastrointestinal DisordersItaly
-
Allakos Inc.CompletedEosinophilic Gastritis | Eosinophilic Gastroenteritis | Eosinophilic DuodenitisUnited States
-
AstraZenecaCompletedEosinophilic Gastritis | Eosinophilic GastroenteritisItaly, Spain, United States, Vietnam, Japan, Netherlands, Ukraine, Poland, Brazil
-
Allakos Inc.CompletedEosinophilic Gastritis | Eosinophilic GastroenteritisUnited States
-
Children's Hospital Medical Center, CincinnatiNational Institutes of Health (NIH); Regeneron PharmaceuticalsActive, not recruitingEosinophilic Gastritis | Eosinophilic GastroenteritisUnited States
-
Regeneron PharmaceuticalsSanofiRecruitingEosinophilic Gastritis | Eosinophilic Duodenitis | Eosinophilic Gastrointestinal DiseaseUnited States, Poland, Italy, Japan, Australia